Fennec Pharmaceuticals Inc. (FENC): Price and Financial Metrics

FENC POWR Grades

• Sentiment is the dimension where FENC ranks best; there it ranks ahead of 94.42% of US stocks.
• The strongest trend for FENC is in Momentum, which has been heading down over the past 48 weeks.
• FENC ranks lowest in Momentum; there it ranks in the 9th percentile.

FENC Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for FENC is 0.01 -- better than just 7.31% of US stocks.
• With a price/sales ratio of 1,438.03, Fennec Pharmaceuticals Inc has a higher such ratio than 99.48% of stocks in our set.
• Equity multiplier, or assets relative to shareholders' equity, comes in at 1.13 for Fennec Pharmaceuticals Inc; that's greater than it is for just 9.19% of US stocks.
• Stocks with similar financial metrics, market capitalization, and price volatility to Fennec Pharmaceuticals Inc are MOTS, SUMO, NTNX, FEYE, and ZUO.
• FENC's SEC filings can be seen here. And to visit Fennec Pharmaceuticals Inc's official web site, go to www.fennecpharma.com.

FENC Valuation Summary

• In comparison to the median Healthcare stock, FENC's price/earnings ratio is 130.96% lower, now standing at -11.3.
• FENC's price/earnings ratio has moved down 3.7 over the prior 203 months.
• FENC's price/sales ratio has moved NA NA over the prior 203 months.

Below are key valuation metrics over time for FENC.

FENC Growth Metrics

• Its 3 year net cashflow from operations growth rate is now at -341.48%.
• Its 2 year price growth rate is now at -40.16%.
• The year over year net cashflow from operations growth rate now stands at -49.46%.

Over the past 70 months, FENC's revenue has gone up $170,000.

The table below shows FENC's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	0.17	-16.749	-18.172
2021-03-31	0.17	-15.439	-19.016
2020-12-31	0.17	-15.595	-18.109
2020-09-30	0	-13.901	-18.481
2020-06-30	0	-10.69	-14.09
2020-03-31	0	-10.33	-13.975

FENC's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• FENC has a Quality Grade of D, ranking ahead of 22.53% of graded US stocks.
• FENC's asset turnover comes in at 0.006 -- ranking 402nd of 677 Pharmaceutical Products stocks.
• AUPH, APLS, and CARA are the stocks whose asset turnover ratios are most correlated with FENC.

The table below shows FENC's key quality metrics over time.